| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.78 | 0.004 | 0.78 | Histamine release inhibitor | 0.689 0.005 DBMET01775 | ||
| 0.684 | 0.026 | 0.713 | Caspase 9 stimulant | 0.713 0.022 DBMET01775 | DBMET01775 | |
| 0.631 | 0.008 | 0.631 | 5 Hydroxytryptamine release inhibitor | 0.532 0.023 DBMET01775 | ||
| 0.64 | 0.043 | 0.658 | Antiinflammatory | 0.658 0.039 DBMET01775 | DBMET01775 | |
| 0.57 | 0.014 | 0.57 | Antioxidant | 0.561 0.014 DBMET01775 | ||
| 0.547 | 0.004 | 0.547 | Lipid peroxidase inhibitor | 0.518 0.005 DBMET01775 | ||
| 0.573 | 0.033 | 0.625 | Cyclophilin D inhibitor | 0.625 0.023 DBMET01775 | DBMET01775 | |
| 0.558 | 0.025 | 0.558 | Aldehyde oxidase inhibitor | 0.343 0.056 DBMET01775 | ||
| 0.524 | 0.008 | 0.524 | Peroxidase inhibitor | 0.386 0.023 DBMET01775 | ||
| 0.501 | 0.019 | 0.507 | Lipoxygenase inhibitor | 0.507 0.018 DBMET01775 | DBMET01775 | |
| 0.508 | 0.043 | 0.54 | Transcription factor NF kappa B inhibitor | 0.54 0.039 DBMET01775 | DBMET01775 | |
| 0.455 | 0.006 | 0.455 | NOS3 expression enhancer | 0.367 0.01 DBMET01775 | ||
| 0.467 | 0.017 | 0.467 | Platelet antagonist | 0.42 0.023 DBMET01775 | ||
| 0.434 | 0.01 | 0.434 | Non-steroidal antiinflammatory agent | 0.383 0.015 DBMET01775 | ||
| 0.422 | 0.004 | 0.422 | Potassium channel large-conductance Ca-activated activator | 0.289 0.004 DBMET01775 | ||
| 0.434 | 0.024 | 0.434 | Free radical scavenger | 0.415 0.026 DBMET01775 | ||
| 0.442 | 0.042 | 0.476 | Cholesterol antagonist | 0.476 0.036 DBMET01775 | DBMET01775 | |
| 0.399 | 0.004 | 0.399 | Potassium channel (Ca-activated) activator | 0.271 0.006 DBMET01775 | ||
| 0.423 | 0.044 | 0.423 | Antithrombotic | 0.414 0.046 DBMET01775 | ||
| 0.383 | 0.004 | 0.383 | Prostaglandin antagonist | 0.333 0.005 DBMET01775 | ||
| 0.425 | 0.049 | 0.425 | Thyroid hormone antagonist | 0.266 0.113 DBMET01775 | ||
| 0.399 | 0.028 | 0.457 | Hypoglycemic | 0.457 0.02 DBMET01775 | DBMET01775 | |
| 0.446 | 0.093 | 0.452 | Apoptosis agonist | 0.452 0.091 DBMET01775 | DBMET01775 | |
| 0.406 | 0.058 | 0.406 | Toll-Like receptor 7 agonist | 0.402 0.059 DBMET01775 | ||
| 0.399 | 0.061 | 0.405 | Toll-Like receptor agonist | 0.405 0.058 DBMET01775 | DBMET01775 | |
| 0.365 | 0.031 | 0.365 | Sodium/bile acid cotransporter inhibitor | 0.338 0.048 DBMET01775 | ||
| 0.387 | 0.057 | 0.387 | Thyroid hormone beta antagonist | 0.234 0.129 DBMET01775 | ||
| 0.406 | 0.077 | 0.472 | Calcium channel L-type activator | 0.472 0.04 DBMET01775 | DBMET01775 | |
| 0.357 | 0.042 | 0.423 | Interleukin 2 agonist | 0.423 0.021 DBMET01775 | DBMET01775 | |
| 0.368 | 0.066 | 0.384 | Vasodilator, peripheral | 0.384 0.061 DBMET01775 | DBMET01775 | |
| 0.311 | 0.01 | 0.311 | Cholesterol synthesis inhibitor | 0.252 0.017 DBMET01775 | ||
| 0.321 | 0.021 | 0.321 | Gastrin inhibitor | 0.27 0.057 DBMET01775 | ||
| 0.32 | 0.025 | 0.32 | Tyrosine 3 hydroxylase inhibitor | 0.258 0.06 DBMET01775 | ||
| 0.307 | 0.014 | 0.322 | Insulin sensitizer | 0.322 0.012 DBMET01775 | DBMET01775 | |
| 0.312 | 0.02 | 0.312 | Diuretic | 0.158 0.071 DBMET01775 | ||
| 0.347 | 0.056 | 0.357 | Vasodilator, coronary | 0.357 0.052 DBMET01775 | DBMET01775 | |
| 0.307 | 0.017 | 0.318 | Monophenol monooxygenase inhibitor | 0.318 0.016 DBMET01775 | DBMET01775 | |
| 0.296 | 0.014 | 0.296 | Cyclooxygenase 1 inhibitor | 0.243 0.023 DBMET01775 | ||
| 0.322 | 0.043 | 0.344 | Hypolipemic | 0.344 0.037 DBMET01775 | DBMET01775 | |
| 0.358 | 0.082 | 0.358 | GABA C receptor rho-3 antagonist | 0.234 0.169 DBMET01775 | ||
| 0.281 | 0.008 | 0.281 | Mediator release inhibitor | 0.218 0.012 DBMET01775 | ||
| 0.29 | 0.019 | 0.29 | Cyclooxygenase inhibitor | 0.256 0.025 DBMET01775 | ||
| 0.287 | 0.019 | 0.353 | Protein kinase stimulant | 0.353 0.012 DBMET01775 | DBMET01775 | |
| 0.301 | 0.033 | 0.301 | Anesthetic general | 0.223 0.063 DBMET01775 | ||
| 0.311 | 0.052 | 0.311 | Insulysin inhibitor | 0.218 0.131 DBMET01775 | ||
| 0.271 | 0.012 | 0.271 | Cystathionine beta-synthase inhibitor | 0.188 0.027 DBMET01775 | ||
| 0.318 | 0.074 | 0.355 | Apoptosis antagonist | 0.355 0.053 DBMET01775 | DBMET01775 | |
| 0.292 | 0.052 | 0.344 | Interleukin agonist | 0.344 0.031 DBMET01775 | DBMET01775 | |
| 0.26 | 0.019 | 0.26 | Succinate dehydrogenase inhibitor | 0.214 0.039 DBMET01775 | ||
| 0.242 | 0.007 | 0.258 | Photosensitizer | 0.258 0.005 DBMET01775 | DBMET01775 | |
| 0.24 | 0.004 | 0.268 | Interferon agonist | 0.268 0.004 DBMET01775 | DBMET01775 | |
| 0.254 | 0.019 | 0.31 | Insulin secretagoues | 0.31 0.011 DBMET01775 | DBMET01775 | |
| 0.249 | 0.016 | 0.249 | 5-Lipoxygenase inhibitor | 0.231 0.019 DBMET01775 | ||
| 0.309 | 0.076 | 0.376 | Immunostimulant | 0.376 0.057 DBMET01775 | DBMET01775 | |
| 0.288 | 0.056 | 0.288 | Antiamyloidogenic | 0.227 0.083 DBMET01775 | ||
| 0.236 | 0.007 | 0.246 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.246 0.006 DBMET01775 | DBMET01775 | |
| 0.236 | 0.009 | 0.236 | Arachidonic acid antagonist | 0.22 0.017 DBMET01775 | ||
| 0.262 | 0.037 | 0.262 | Dual specificity phosphatase 3 inhibitor | 0.228 0.048 DBMET01775 | ||
| 0.236 | 0.015 | 0.236 | Ferrochelatase inhibitor | 0.126 0.05 DBMET01775 | ||
| 0.225 | 0.004 | 0.225 | Prostaglandin D2 antagonist | 0.135 0.004 DBMET01775 | ||
| 0.235 | 0.015 | 0.245 | Neurotrophic factor | 0.245 0.013 DBMET01775 | DBMET01775 | |
| 0.292 | 0.073 | 0.292 | Spasmolytic | 0.264 0.085 DBMET01775 | ||
| 0.232 | 0.015 | 0.232 | GABA C receptor agonist | 0.136 0.04 DBMET01775 | ||
| 0.275 | 0.06 | 0.275 | 5 Hydroxytryptamine uptake stimulant | 0.249 0.082 DBMET01775 | ||
| 0.22 | 0.006 | 0.22 | Aldose reductase inhibitor | 0.163 0.009 DBMET01775 | ||
| 0.254 | 0.042 | 0.276 | Hepatoprotectant | 0.276 0.037 DBMET01775 | DBMET01775 | |
| 0.302 | 0.09 | 0.302 | Calcium channel activator | 0.259 0.137 DBMET01775 | ||
| 0.249 | 0.038 | 0.249 | Dual specificity phosphatase inhibitor | 0.203 0.053 DBMET01775 | ||
| 0.269 | 0.06 | 0.269 | Vasodilator | 0.264 0.062 DBMET01775 | ||
| 0.233 | 0.026 | 0.255 | Alpha-N-acetylglucosaminidase inhibitor | 0.255 0.022 DBMET01775 | DBMET01775 | |
| 0.214 | 0.01 | 0.246 | Mucolytic | 0.246 0.007 DBMET01775 | DBMET01775 | |
| 0.22 | 0.017 | 0.259 | Expectorant | 0.259 0.012 DBMET01775 | DBMET01775 | |
| 0.225 | 0.022 | 0.225 | Aldehyde dehydrogenase inhibitor | 0.22 0.023 DBMET01775 | ||
| 0.226 | 0.024 | 0.226 | Cyclooxygenase 2 inhibitor | 0.202 0.03 DBMET01775 | ||
| 0.234 | 0.033 | 0.264 | Amylase inhibitor | 0.264 0.024 DBMET01775 | DBMET01775 | |
| 0.202 | 0.002 | 0.202 | Retinoid X alpha receptor agonist | 0.134 0.004 DBMET01775 | ||
| 0.319 | 0.119 | 0.319 | 15-Lipoxygenase inhibitor | |||
| 0.205 | 0.012 | 0.288 | Histidine decarboxylase inhibitor | 0.288 0.007 DBMET01775 | DBMET01775 | |
| 0.225 | 0.033 | 0.225 | Interferon gamma antagonist | 0.19 0.045 DBMET01775 | ||
| 0.224 | 0.033 | 0.224 | Melanin inhibitor | 0.213 0.036 DBMET01775 | ||
| 0.243 | 0.054 | 0.243 | RNA-directed DNA polymerase inhibitor | 0.243 0.054 DBMET01775 | ||
| 0.194 | 0.008 | 0.194 | DOPA decarboxylase inhibitor | 0.157 0.018 DBMET01775 | ||
| 0.194 | 0.01 | 0.194 | ABCA1 expression enhancer | 0.141 0.02 DBMET01775 | ||
| 0.222 | 0.039 | 0.256 | Protein-tyrosine phosphatase inhibitor | 0.256 0.029 DBMET01775 | DBMET01775 | |
| 0.236 | 0.054 | 0.236 | Platelet adhesion inhibitor | 0.218 0.062 DBMET01775 | ||
| 0.211 | 0.037 | 0.211 | Phospholipase A2 inhibitor | 0.2 0.042 DBMET01775 | ||
| 0.226 | 0.054 | 0.226 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.069 DBMET01775 | ||
| 0.27 | 0.098 | 0.27 | 12-Lipoxygenase inhibitor | 0.227 0.125 DBMET01775 | ||
| 0.181 | 0.01 | 0.181 | Keratolytic | 0.153 0.014 DBMET01775 | ||
| 0.185 | 0.014 | 0.229 | Porphobilinogen synthase inhibitor | 0.229 0.009 DBMET01775 | DBMET01775 | |
| 0.208 | 0.039 | 0.214 | Phospholipase C inhibitor | 0.214 0.036 DBMET01775 | DBMET01775 | |
| 0.221 | 0.053 | 0.221 | P-glycoprotein inhibitor | 0.172 0.088 DBMET01775 | ||
| 0.244 | 0.078 | 0.244 | Superoxide dismutase inhibitor | 0.166 0.162 DBMET01775 | ||
| 0.171 | 0.008 | 0.225 | Leukotriene antagonist | 0.225 0.005 DBMET01775 | DBMET01775 | |
| 0.287 | 0.124 | 0.287 | Immunosuppressant | 0.274 0.132 DBMET01775 | ||
| 0.217 | 0.062 | 0.235 | Nitric oxide antagonist | 0.235 0.056 DBMET01775 | DBMET01775 | |
| 0.164 | 0.01 | 0.164 | Peroxisome proliferator-activated receptor gamma agonist | 0.149 0.013 DBMET01775 | ||
| 0.157 | 0.003 | 0.157 | Retinoid X receptor agonist | 0.104 0.004 DBMET01775 | ||
| 0.173 | 0.019 | 0.173 | Papain-like protease (SARS coronavirus) inhibitor | 0.125 0.07 DBMET01775 | ||
| 0.19 | 0.036 | 0.19 | Mannose-6-phosphate isomerase inhibitor | 0.183 0.04 DBMET01775 | ||
| 0.157 | 0.004 | 0.179 | Interferon inducer | 0.179 0.004 DBMET01775 | DBMET01775 | |
| 0.167 | 0.016 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.158 0.027 DBMET01775 | ||
| 0.169 | 0.021 | 0.169 | Adenylate kinase inhibitor | 0.15 0.026 DBMET01775 | ||
| 0.174 | 0.031 | 0.174 | Cyclooxygenase 3 inhibitor | 0.159 0.041 DBMET01775 | ||
| 0.159 | 0.018 | 0.169 | Triose-phosphate isomerase inhibitor | 0.169 0.015 DBMET01775 | DBMET01775 | |
| 0.216 | 0.076 | 0.216 | Interleukin antagonist | |||
| 0.181 | 0.04 | 0.181 | NADPH oxidase inhibitor | 0.161 0.048 DBMET01775 | ||
| 0.16 | 0.02 | 0.16 | Creatine kinase inhibitor | 0.112 0.047 DBMET01775 | ||
| 0.162 | 0.024 | 0.162 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.032 DBMET01775 | ||
| 0.164 | 0.027 | 0.164 | Vanilloid 1 agonist | 0.158 0.031 DBMET01775 | ||
| 0.195 | 0.06 | 0.195 | Lipocortins synthesis antagonist | 0.166 0.085 DBMET01775 | ||
| 0.154 | 0.022 | 0.156 | Uric acid excretion stimulant | 0.156 0.021 DBMET01775 | DBMET01775 | |
| 0.168 | 0.039 | 0.203 | Protein-tyrosine phosphatase 1B inhibitor | 0.203 0.028 DBMET01775 | DBMET01775 | |
| 0.173 | 0.045 | 0.173 | Bone formation stimulant | 0.148 0.06 DBMET01775 | ||
| 0.182 | 0.055 | 0.182 | ATPase inhibitor | |||
| 0.155 | 0.028 | 0.155 | TRPA1 agonist | 0.102 0.084 DBMET01775 | ||
| 0.224 | 0.097 | 0.243 | DNA damaging | 0.243 0.084 DBMET01775 | DBMET01775 | |
| 0.141 | 0.015 | 0.141 | Glutamate decarboxylase inhibitor | 0.096 0.032 DBMET01775 | ||
| 0.156 | 0.032 | 0.181 | Xanthine oxidase inhibitor | 0.181 0.024 DBMET01775 | DBMET01775 | |
| 0.201 | 0.077 | 0.201 | Amyloid beta aggregation inhibitor | |||
| 0.138 | 0.015 | 0.138 | HIV-1 integrase (3'-Processing) inhibitor | 0.126 0.018 DBMET01775 | ||
| 0.137 | 0.015 | 0.137 | Glutathione S-transferase inhibitor | 0.099 0.038 DBMET01775 | ||
| 0.276 | 0.154 | 0.276 | Antibacterial | 0.253 0.174 DBMET01775 | ||
| 0.13 | 0.008 | 0.13 | Maillard reaction inhibitor | 0.122 0.01 DBMET01775 | ||
| 0.145 | 0.025 | 0.145 | Estrogen antagonist | 0.129 0.04 DBMET01775 | ||
| 0.155 | 0.036 | 0.155 | Heat shock protein 70 antagonist | 0.134 0.101 DBMET01775 | ||
| 0.166 | 0.048 | 0.166 | Interleukin 1 antagonist | |||
| 0.145 | 0.028 | 0.181 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.181 0.019 DBMET01775 | DBMET01775 | |
| 0.144 | 0.028 | 0.144 | HIV-1 integrase (Overall Integration) inhibitor | 0.134 0.032 DBMET01775 | ||
| 0.123 | 0.007 | 0.146 | Leukotriene B4 antagonist | 0.146 0.005 DBMET01775 | DBMET01775 | |
| 0.136 | 0.023 | 0.136 | Cathepsin G inhibitor | 0.132 0.024 DBMET01775 | ||
| 0.138 | 0.025 | 0.138 | Electrolyte absorption antagonist | 0.092 0.071 DBMET01775 | ||
| 0.127 | 0.015 | 0.127 | HIV-1 integrase (Strand Transfer) inhibitor | 0.116 0.018 DBMET01775 | ||
| 0.133 | 0.021 | 0.133 | Estrogen receptor beta antagonist | 0.119 0.033 DBMET01775 | ||
| 0.154 | 0.043 | 0.154 | Antibacterial (Helicobacter pylori) | 0.15 0.046 DBMET01775 | ||
| 0.161 | 0.053 | 0.161 | Alkaline phosphatase inhibitor | 0.132 0.074 DBMET01775 | ||
| 0.133 | 0.025 | 0.172 | Carbonic anhydrase VI inhibitor | 0.172 0.017 DBMET01775 | DBMET01775 | |
| 0.127 | 0.021 | 0.13 | Ornithine decarboxylase inhibitor | 0.13 0.019 DBMET01775 | DBMET01775 | |
| 0.135 | 0.029 | 0.135 | GABA C receptor rho-1 antagonist | 0.091 0.077 DBMET01775 | ||
| 0.143 | 0.039 | 0.143 | Interleukin 8 antagonist | |||
| 0.204 | 0.1 | 0.204 | Aryl hydrocarbon receptor agonist | 0.15 0.136 DBMET01775 | ||
| 0.147 | 0.044 | 0.147 | Protein kinase (CK2) alpha inhibitor | 0.1 0.076 DBMET01775 | ||
| 0.105 | 0.005 | 0.105 | DNA helicase inhibitor | 0.082 0.01 DBMET01775 | ||
| 0.115 | 0.015 | 0.115 | Prostaglandin EP2 antagonist | 0.101 0.019 DBMET01775 | ||
| 0.196 | 0.096 | 0.212 | Nitric-oxide synthase stimulant | 0.212 0.07 DBMET01775 | DBMET01775 | |
| 0.113 | 0.015 | 0.113 | NMDA receptor agonist | 0.074 0.033 DBMET01775 | ||
| 0.113 | 0.015 | 0.113 | Biliverdin reductase inhibitor | 0.066 0.035 DBMET01775 | ||
| 0.109 | 0.012 | 0.109 | Peroxisome proliferator-activated receptor gamma antagonist | 0.098 0.017 DBMET01775 | ||
| 0.117 | 0.02 | 0.117 | Estrogen receptor alpha antagonist | 0.091 0.034 DBMET01775 | ||
| 0.208 | 0.111 | 0.235 | DNA synthesis inhibitor | 0.235 0.078 DBMET01775 | DBMET01775 | |
| 0.118 | 0.021 | 0.118 | Bile acid receptor antagonist | 0.11 0.031 DBMET01775 | ||
| 0.098 | 0.004 | 0.105 | Leukotriene C antagonist | 0.105 0.004 DBMET01775 | DBMET01775 | |
| 0.192 | 0.099 | 0.246 | Angiogenesis stimulant | 0.246 0.072 DBMET01775 | DBMET01775 | |
| 0.185 | 0.093 | 0.185 | Platelet aggregation inhibitor | |||
| 0.108 | 0.016 | 0.108 | Ca(v)3.1 blocker | 0.081 0.058 DBMET01775 | ||
| 0.101 | 0.01 | 0.101 | Glutamate (mGluR6) antagonist | 0.088 0.017 DBMET01775 | ||
| 0.118 | 0.03 | 0.118 | NADH dehydrogenase inhibitor | 0.107 0.037 DBMET01775 | ||
| 0.131 | 0.043 | 0.131 | GABA C receptor antagonist | |||
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | 0.071 0.041 DBMET01775 | ||
| 0.154 | 0.068 | 0.154 | GABA C receptor rho-2 antagonist | |||
| 0.117 | 0.031 | 0.117 | Topoisomerase II alpha inhibitor | 0.105 0.037 DBMET01775 | ||
| 0.181 | 0.097 | 0.258 | Neurotrophic factor enhancer | 0.258 0.034 DBMET01775 | DBMET01775 | |
| 0.099 | 0.017 | 0.099 | NMDA receptor glycine site agonist | 0.061 0.045 DBMET01775 | ||
| 0.216 | 0.134 | 0.256 | Hypoxia-inducible factor 1 alpha inhibitor | 0.256 0.095 DBMET01775 | DBMET01775 | |
| 0.13 | 0.048 | 0.153 | MAO A inhibitor | 0.153 0.04 DBMET01775 | DBMET01775 | |
| 0.117 | 0.037 | 0.117 | Alcohol dehydrogenase inhibitor | 0.088 0.067 DBMET01775 | ||
| 0.147 | 0.067 | 0.15 | Adenylate cyclase stimulant | 0.15 0.062 DBMET01775 | DBMET01775 | |
| 0.22 | 0.142 | 0.295 | Immunomodulator | 0.295 0.085 DBMET01775 | DBMET01775 | |
| 0.116 | 0.039 | 0.116 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.076 DBMET01775 | ||
| 0.146 | 0.068 | 0.146 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.091 | 0.014 | 0.091 | Peroxisome proliferator-activated receptor alpha agonist | 0.08 0.018 DBMET01775 | ||
| 0.125 | 0.05 | 0.125 | Aminopeptidase B inhibitor | 0.089 0.073 DBMET01775 | ||
| 0.218 | 0.145 | 0.226 | Caspase 3 stimulant | 0.226 0.135 DBMET01775 | DBMET01775 | |
| 0.172 | 0.099 | 0.172 | Pyruvate kinase inhibitor | |||
| 0.163 | 0.091 | 0.163 | DNA methyltransferase I inhibitor | 0.137 0.12 DBMET01775 | ||
| 0.082 | 0.011 | 0.082 | Thromboxane synthase inhibitor | 0.063 0.023 DBMET01775 | ||
| 0.099 | 0.031 | 0.099 | Glutamate dehydrogenase inhibitor | 0.082 0.043 DBMET01775 | ||
| 0.075 | 0.007 | 0.075 | Peroxisome proliferator-activated receptor delta antagonist | 0.046 0.011 DBMET01775 | ||
| 0.073 | 0.004 | 0.08 | Leukotriene C4 antagonist | 0.08 0.004 DBMET01775 | DBMET01775 | |
| 0.129 | 0.061 | 0.141 | Topoisomerase II inhibitor | 0.141 0.054 DBMET01775 | DBMET01775 | |
| 0.097 | 0.029 | 0.097 | GABA aminotransferase inhibitor | 0.074 0.054 DBMET01775 | ||
| 0.153 | 0.085 | 0.153 | Interleukin 6 antagonist | |||
| 0.071 | 0.004 | 0.071 | Vanilloid 3 antagonist | 0.051 0.008 DBMET01775 | ||
| 0.169 | 0.102 | 0.169 | DNA methylase inhibitor | 0.139 0.128 DBMET01775 | ||
| 0.071 | 0.006 | 0.071 | Retinoic acid alpha receptor agonist | 0.059 0.009 DBMET01775 | ||
| 0.291 | 0.226 | 0.291 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.112 | 0.047 | 0.112 | Anabolic | 0.107 0.053 DBMET01775 | ||
| 0.086 | 0.022 | 0.086 | Aminopeptidase microsomal inhibitor | 0.068 0.033 DBMET01775 | ||
| 0.095 | 0.031 | 0.095 | Estrogen-related receptor beta agonist | |||
| 0.085 | 0.022 | 0.085 | Alcohol oxidase inhibitor | 0.049 0.047 DBMET01775 | ||
| 0.126 | 0.063 | 0.126 | Adenylate cyclase inhibitor | 0.114 0.073 DBMET01775 | ||
| 0.066 | 0.004 | 0.066 | Retinoid X receptor antagonist | 0.049 0.013 DBMET01775 | ||
| 0.115 | 0.054 | 0.115 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.112 | 0.051 | 0.127 | Carbonic anhydrase III inhibitor | 0.127 0.04 DBMET01775 | DBMET01775 | |
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | |||
| 0.149 | 0.09 | 0.149 | Mcl-1 antagonist | 0.124 0.12 DBMET01775 | ||
| 0.092 | 0.033 | 0.092 | CDC25A inhibitor | 0.083 0.04 DBMET01775 | ||
| 0.075 | 0.016 | 0.075 | Aconitate hydratase inhibitor | 0.052 0.036 DBMET01775 | ||
| 0.11 | 0.051 | 0.124 | UDP-glucose 4-epimerase inhibitor | 0.124 0.041 DBMET01775 | DBMET01775 | |
| 0.063 | 0.004 | 0.063 | Prostaglandin EP4 agonist | 0.032 0.007 DBMET01775 | ||
| 0.082 | 0.025 | 0.082 | Argininosuccinate synthase inhibitor | 0.064 0.034 DBMET01775 | ||
| 0.061 | 0.005 | 0.061 | Free fatty acid receptor 1 antagonist | 0.054 0.007 DBMET01775 | ||
| 0.07 | 0.015 | 0.07 | CD45 antagonist | 0.069 0.016 DBMET01775 | ||
| 0.091 | 0.035 | 0.1 | Phosphofructokinase-1 inhibitor | 0.1 0.032 DBMET01775 | DBMET01775 | |
| 0.088 | 0.033 | 0.088 | HIV-1 integrase inhibitor | 0.075 0.042 DBMET01775 | ||
| 0.087 | 0.032 | 0.087 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.053 DBMET01775 | ||
| 0.118 | 0.064 | 0.118 | Interleukin 1b antagonist | |||
| 0.064 | 0.01 | 0.078 | Cytokine production stimulant | 0.078 0.005 DBMET01775 | DBMET01775 | |
| 0.079 | 0.025 | 0.079 | Purinergic P2X1 antagonist | 0.067 0.034 DBMET01775 | ||
| 0.058 | 0.004 | 0.058 | Retinoid X alpha receptor antagonist | 0.043 0.012 DBMET01775 | ||
| 0.061 | 0.008 | 0.061 | Prostaglandin agonist | 0.053 0.009 DBMET01775 | ||
| 0.064 | 0.013 | 0.064 | Urate transporter 1 inhibitor | 0.038 0.028 DBMET01775 | ||
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | |||
| 0.056 | 0.006 | 0.056 | ATP citrate lysase inhibitor | 0.043 0.011 DBMET01775 | ||
| 0.096 | 0.046 | 0.105 | Interleukin 5 antagonist | 0.105 0.036 DBMET01775 | DBMET01775 | |
| 0.123 | 0.073 | 0.183 | MAO inhibitor | 0.183 0.047 DBMET01775 | DBMET01775 | |
| 0.06 | 0.01 | 0.06 | Peroxisome proliferator-activated receptor delta agonist | 0.056 0.011 DBMET01775 | ||
| 0.065 | 0.017 | 0.065 | Heparanase inhibitor | 0.059 0.025 DBMET01775 | ||
| 0.059 | 0.013 | 0.085 | Liver X receptor alpha agonist | 0.085 0.006 DBMET01775 | DBMET01775 | |
| 0.085 | 0.038 | 0.085 | Aminopeptidase I inhibitor | |||
| 0.115 | 0.069 | 0.115 | Cell adhesion inhibitor | |||
| 0.121 | 0.076 | 0.141 | Toll-Like receptor 2 antagonist | 0.141 0.059 DBMET01775 | DBMET01775 | |
| 0.11 | 0.065 | 0.11 | Chelator | 0.107 0.068 DBMET01775 | ||
| 0.066 | 0.022 | 0.066 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.06 | 0.017 | 0.06 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 DBMET01775 | ||
| 0.087 | 0.044 | 0.087 | Catalase inhibitor | |||
| 0.065 | 0.022 | 0.065 | Aminopeptidase N inhibitor | 0.048 0.034 DBMET01775 | ||
| 0.047 | 0.005 | 0.047 | Thyroid hormone agonist | 0.04 0.006 DBMET01775 | ||
| 0.122 | 0.082 | 0.122 | Interleukin 4 antagonist | 0.115 0.092 DBMET01775 | ||
| 0.085 | 0.046 | 0.115 | Carbonic anhydrase XIII inhibitor | 0.115 0.032 DBMET01775 | DBMET01775 | |
| 0.077 | 0.04 | 0.077 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.041 | 0.005 | 0.041 | Retinoid X beta receptor agonist | 0.022 0.013 DBMET01775 | ||
| 0.057 | 0.021 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.018 DBMET01775 | DBMET01775 | |
| 0.075 | 0.04 | 0.108 | Leukotriene synthesis inhibitor | 0.108 0.022 DBMET01775 | DBMET01775 | |
| 0.178 | 0.143 | 0.178 | 5 Hydroxytryptamine release stimulant | |||
| 0.041 | 0.007 | 0.041 | Retinoid X gamma receptor agonist | 0.023 0.017 DBMET01775 | ||
| 0.087 | 0.053 | 0.094 | Antineoplastic antibiotic | 0.094 0.049 DBMET01775 | DBMET01775 | |
| 0.043 | 0.01 | 0.043 | Leukotriene B4 receptor 1 antagonist | 0.04 0.012 DBMET01775 | ||
| 0.048 | 0.016 | 0.048 | Kainate receptor agonist | |||
| 0.14 | 0.107 | 0.14 | Antipruritic | |||
| 0.062 | 0.031 | 0.062 | Thromboxane antagonist | 0.053 0.039 DBMET01775 | ||
| 0.059 | 0.027 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.042 DBMET01775 | ||
| 0.074 | 0.044 | 0.074 | Prostaglandin-E synthase inhibitor | 0.062 0.061 DBMET01775 | ||
| 0.041 | 0.012 | 0.074 | Leukotriene D4 antagonist | 0.074 0.007 DBMET01775 | DBMET01775 | |
| 0.049 | 0.02 | 0.049 | GABA B receptor antagonist | |||
| 0.096 | 0.068 | 0.096 | Protein kinase (CK2) inhibitor | |||
| 0.038 | 0.01 | 0.038 | Peroxisome proliferator-activated receptor alpha antagonist | 0.028 0.012 DBMET01775 | ||
| 0.032 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | 0.021 0.007 DBMET01775 | ||
| 0.035 | 0.009 | 0.035 | Prostaglandin E2 agonist | 0.032 0.01 DBMET01775 | ||
| 0.048 | 0.022 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET01775 | ||
| 0.041 | 0.015 | 0.041 | Glutamate (mGluR8) antagonist | 0.036 0.025 DBMET01775 | ||
| 0.113 | 0.088 | 0.136 | DNA repair enzyme inhibitor | 0.136 0.046 DBMET01775 | DBMET01775 | |
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | 0.02 0.015 DBMET01775 | ||
| 0.065 | 0.041 | 0.069 | Nitric oxide donor | 0.069 0.034 DBMET01775 | DBMET01775 | |
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET01775 | ||
| 0.044 | 0.021 | 0.044 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET01775 | ||
| 0.065 | 0.041 | 0.065 | Transcription factor RelA inhibitor | |||
| 0.064 | 0.041 | 0.069 | Protease activated receptor antagonist | 0.069 0.035 DBMET01775 | DBMET01775 | |
| 0.069 | 0.047 | 0.078 | Carbonic anhydrase VA inhibitor | 0.078 0.038 DBMET01775 | DBMET01775 | |
| 0.037 | 0.015 | 0.037 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.062 | 0.04 | 0.062 | Aromatase inhibitor | |||
| 0.031 | 0.009 | 0.031 | Retinoic acid receptor agonist | 0.026 0.012 DBMET01775 | ||
| 0.053 | 0.031 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 DBMET01775 | ||
| 0.082 | 0.062 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.169 | 0.149 | 0.169 | Peptidyltransferase inhibitor | |||
| 0.029 | 0.009 | 0.029 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 DBMET01775 | ||
| 0.047 | 0.028 | 0.047 | Sphingosine 1-phosphate receptor agonist | 0.046 0.028 DBMET01775 | ||
| 0.03 | 0.011 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.018 DBMET01775 | ||
| 0.06 | 0.043 | 0.06 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 DBMET01775 | ||
| 0.022 | 0.005 | 0.022 | Thyroid hormone alpha agonist | 0.016 0.012 DBMET01775 | ||
| 0.095 | 0.078 | 0.103 | AMP-activated protein kinase stimulant | 0.103 0.067 DBMET01775 | DBMET01775 | |
| 0.028 | 0.011 | 0.028 | Glutamate (mGluR1) agonist | 0.023 0.02 DBMET01775 | ||
| 0.092 | 0.076 | 0.092 | Gastric antisecretory | |||
| 0.034 | 0.018 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.058 | 0.042 | 0.058 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.032 | 0.016 | 0.05 | Liver X receptor alpha antagonist | 0.05 0.006 DBMET01775 | DBMET01775 | |
| 0.027 | 0.011 | 0.027 | Glutamate (mGluR1a) agonist | |||
| 0.093 | 0.078 | 0.117 | Carbonic anhydrase XV inhibitor | 0.117 0.049 DBMET01775 | DBMET01775 | |
| 0.046 | 0.031 | 0.046 | Adenylate cyclase 1 inhibitor | |||
| 0.07 | 0.055 | 0.07 | Glycine receptor agonist | |||
| 0.035 | 0.021 | 0.057 | Liver X receptor beta agonist | 0.057 0.009 DBMET01775 | DBMET01775 | |
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.086 | 0.072 | 0.086 | Breast cancer-resistant protein inhibitor | |||
| 0.081 | 0.067 | 0.081 | Vanilloid agonist | |||
| 0.037 | 0.024 | 0.037 | Glutamate (mGluR3) antagonist | |||
| 0.049 | 0.036 | 0.049 | Thromboxane A2 antagonist | |||
| 0.058 | 0.045 | 0.058 | Bcl-xL inhibitor | 0.056 0.053 DBMET01775 | ||
| 0.1 | 0.087 | 0.1 | Proteasome inhibitor | |||
| 0.223 | 0.21 | 0.223 | DNA directed DNA polymerase inhibitor | |||
| 0.034 | 0.022 | 0.034 | Prostacyclin antagonist | 0.03 0.025 DBMET01775 | ||
| 0.119 | 0.107 | 0.122 | Farnesoid X receptor antagonist | 0.122 0.098 DBMET01775 | DBMET01775 | |
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.101 | 0.089 | 0.101 | Microtubule formation inhibitor | |||
| 0.221 | 0.209 | 0.221 | DNA polymerase beta inhibitor | |||
| 0.028 | 0.016 | 0.028 | Retinoid X gamma receptor antagonist | |||
| 0.031 | 0.02 | 0.031 | Prostaglandin EP3 antagonist | |||
| 0.048 | 0.037 | 0.048 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET01775 | ||
| 0.02 | 0.01 | 0.02 | Antibiotic Anthracycline-like | |||
| 0.027 | 0.017 | 0.041 | Prostaglandin EP4 antagonist | 0.041 0.01 DBMET01775 | DBMET01775 | |
| 0.137 | 0.128 | 0.137 | Psychostimulant | |||
| 0.018 | 0.011 | 0.021 | G-protein-coupled receptor 120 agonist | 0.021 0.009 DBMET01775 | DBMET01775 | |
| 0.06 | 0.054 | 0.073 | Carbonic anhydrase V inhibitor | 0.073 0.04 DBMET01775 | DBMET01775 | |
| 0.018 | 0.012 | 0.024 | Free fatty acid receptor 1 agonist | 0.024 0.008 DBMET01775 | DBMET01775 | |
| 0.044 | 0.038 | 0.044 | Aldosterone antagonist | |||
| 0.041 | 0.035 | 0.054 | Liver X receptor agonist | 0.054 0.02 DBMET01775 | DBMET01775 | |
| 0.023 | 0.018 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.098 | 0.093 | 0.098 | Beta amyloid protein antagonist | |||
| 0.032 | 0.027 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.044 | 0.04 | 0.044 | Cholesterol esterase inhibitor | |||
| 0.042 | 0.038 | 0.047 | Adenosine deaminase inhibitor | 0.047 0.033 DBMET01775 | DBMET01775 | |
| 0.026 | 0.023 | 0.05 | Liver X receptor beta antagonist | 0.05 0.008 DBMET01775 | DBMET01775 | |
| 0.067 | 0.063 | 0.081 | Na+ K+ transporting ATPase inhibitor | 0.081 0.05 DBMET01775 | DBMET01775 | |
| 0.015 | 0.012 | 0.015 | Prostacyclin agonist | 0.015 0.012 DBMET01775 | ||
| 0.028 | 0.025 | 0.049 | Liver X receptor antagonist | 0.049 0.01 DBMET01775 | DBMET01775 | |
| 0.019 | 0.016 | 0.019 | Retinoic acid alpha receptor antagonist | |||
| 0.009 | 0.006 | 0.009 | Thyroid hormone beta agonist | |||
| 0.021 | 0.019 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.044 | 0.042 | 0.069 | Prostaglandin E2 antagonist | 0.069 0.024 DBMET01775 | DBMET01775 | |
| 0.09 | 0.089 | 0.09 | Beta glucuronidase inhibitor | |||
| 0.027 | 0.026 | 0.029 | Prostaglandin D2 agonist | 0.029 0.024 DBMET01775 | DBMET01775 | |
| 0.038 | 0.037 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.039 | 0.044 | 0.042 | Estrogen agonist | 0.042 0.041 DBMET01775 | DBMET01775 | |
| 0.027 | 0.032 | 0.029 | Elastase 3B inhibitor | 0.029 0.027 DBMET01775 | DBMET01775 | |
| 0.027 | 0.032 | 0.029 | Elastase 3A inhibitor | 0.029 0.027 DBMET01775 | DBMET01775 | |
| 0.027 | 0.032 | 0.029 | Elastase 2B inhibitor | 0.029 0.027 DBMET01775 | DBMET01775 | |
| 0.036 | 0.04 | 0.049 | Guanylate cyclase inhibitor | 0.049 0.022 DBMET01775 | DBMET01775 | |
| 0.082 | 0.088 | 0.136 | Topoisomerase I inhibitor | 0.136 0.047 DBMET01775 | DBMET01775 | |
| 0.035 | 0.046 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.034 DBMET01775 | DBMET01775 | |
| 0.041 | 0.054 | 0.06 | Topoisomerase II beta inhibitor | 0.06 0.022 DBMET01775 | DBMET01775 | |
| 0.045 | 0.058 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 DBMET01775 | DBMET01775 | |
| 0.039 | 0.059 | 0.059 | Xanthine dehydrogenase inhibitor | 0.059 0.039 DBMET01775 | DBMET01775 | |
| 0.066 | 0.089 | 0.104 | MAO B inhibitor | 0.104 0.058 DBMET01775 | DBMET01775 | |
| 0.123 | 0.155 | 0.139 | I kappa B kinase epsilon inhibitor | 0.139 0.132 DBMET01775 | DBMET01775 | |
| 0.031 | 0.068 | 0.049 | Carbonic anhydrase VB inhibitor | 0.049 0.046 DBMET01775 | DBMET01775 | |
| 0.04 | 0.076 | 0.061 | Selectin antagonist | 0.061 0.048 DBMET01775 | DBMET01775 | |
| 0.08 | 0.118 | 0.126 | Alkylator | 0.126 0.063 DBMET01775 | DBMET01775 | |
| 0.045 | 0.097 | 0.114 | Phosphodiesterase 4D inhibitor | 0.114 0.031 DBMET01775 | DBMET01775 | |
| 0.049 | 0.234 | 0.084 | Transcription factor NF kappa B stimulant | 0.084 0.061 DBMET01775 | DBMET01775 | |
| 0.023 | 0.376 | 0.103 | Bronchodilator | 0.103 0.06 DBMET01775 | DBMET01775 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |